All stock lists
Lineage Cell Therapeutics, Inc. (LCTX)
NYSE: LCTX · Real-Time Price · USD
Healthcare · Biotechnology
$0.80-$0.12 (-13.07%)
Insider Score
76/ 100
LCTX Insider Score
Bullish1 qualifying trade · 1 insider · $17.10K bought in the last 90 days
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
LCTX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New LCTX patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to LCTX from public contracts
Source: USAspending.gov
Recently reported changes in LCTX holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing LCTX, reported under the STOCK Act.
| No congressional trades recorded for LCTX. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
